[1]
|
Pawlak, K., Gabryel, P., Kujawska, A., Kasprzyk, M., Piwkowski, C., Kuffel, B. and Dyszkiewicz, W. (2018) Long-Term Results of Surgical Treatment of Non-Small Cell Lung Cancer in Patients over 75 Years of Age. Kardi-ochirugia i Torakochirurgia Polska, 15, 65-71. https://doi.org/10.5114/kitp.2018.76470
|
[2]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30.
https://doi.org/10.3322/caac.21590
|
[3]
|
Liu, X., Huang, G., Zhang, J., Zhang, L. and Liang, Z. (2020) Prognostic and Clinicopathological Significance of Long Noncoding RNA MALAT-1 Expression in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis. PLOS ONE, 15, e0240321. https://doi.org/10.1371/journal.pone.0240321
|
[4]
|
Yu, H., Shen, Z.A., Zhou, Y.K. and Du, P.F. (2022) Recent Advances in Predicting Protein-lncRNA Interactions Using Machine Learning Methods. Current Gene Therapy, 22, 228-244.
https://doi.org/10.2174/1566523221666210712190718
|
[5]
|
Li, X., Sun, D., Zhao, T. and Zhang, Z. (2020) Long Non-Coding RNA ROR Confers Arsenic Trioxide Resistance to HepG2 Cells by Inhibiting p53 Expression. European Journal of Pharmacology, 872, Article ID: 172982.
https://doi.org/10.1016/j.ejphar.2020.172982
|
[6]
|
Wang, X., Lai, Q., He, J., Li, Q., Ding, J., Lan, Z., Gu, C., Yan, Q., Fang, Y., Zhao, X. and Liu, S. (2019) LncRNA SNHG6 Promotes Proliferation, Invasion and Migration in Colorec-tal Cancer Cells by Activating TGF-β/Smad Signaling Pathway via Targeting UPF1 and Inducing EMT via Regulation of ZEB1. International Journal of Medical Sciences, 16, 51-59. https://doi.org/10.7150/ijms.27359
|
[7]
|
Sun, Z., Shao, B., Liu, Z., Dang, Q., Guo, Y., Chen, C., Guo, Y., Chen, Z., Liu, J., Hu, S., Yuan, W. and Zhou, Q. (2021) LINC01296/miR-141-3p/ZEB1-ZEB2 Axis Promotes Tumor Metastasis via Enhancing Epithelial-Mesenchymal Transi-tion Process. Journal of Cancer, 12, 2723-2734. https://doi.org/10.7150/jca.55626
|
[8]
|
Chen, R., Manochakian, R., James, L., Azzouqa, A.G., Shi, H., Zhang, Y., Zhao, Y., Zhou, K. and Lou, Y. (2020) Emerging Therapeutic Agents for Advanced Non-Small Cell Lung Cancer. Journal of Hematology & Oncology, 13, Article No. 58. https://doi.org/10.1186/s13045-020-00881-7
|
[9]
|
Li, Y., Zhang, H., Guo, J., Li, W., Wang, X., Zhang, C., Sun, Q. and Ma, Z. (2021) Downregulation of LINC01296 Suppresses Non-Small-Cell Lung Cancer via Targeting miR-143-3p/ATG2B. Acta Biochimica et Biophysica Sinica, 53, 1681-1690. https://doi.org/10.1093/abbs/gmab149
|
[10]
|
Wang, C., Wang, L., Ding, Y., Lu, X., Zhang, G., Yang, J., Zheng, H., Wang, H., Jiang, Y. and Xu, L. (2017) LncRNA Structural Characteristics in Epigenetic Regulation. International Jour-nal of Molecular Sciences, 18, Article 2659.
https://doi.org/10.3390/ijms18122659
|
[11]
|
Hao, L., Wu, W., Xu, Y., Chen, Y., Meng, C., Yun, J. and Wang, X. (2023) LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer. Molecules, 28, Article 2126. https://doi.org/10.3390/molecules28052126
|
[12]
|
Sun, Y. and Ma, L. (2019) New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis. Cancers, 11, Article 216. https://doi.org/10.3390/cancers11020216
|
[13]
|
Wang, D., Zhang, S., Zhao, M. and Chen, F. (2020) LncRNA MALAT1 Accelerates Non-Small Cell Lung Cancer Progression via Regulating miR-185-5p/MDM4 Axis. Cancer Medicine, 9, 9138-9149.
https://doi.org/10.1002/cam4.3570
|
[14]
|
Chen, J., Liu, X., Xu, Y., Zhang, K., Huang, J., Pan, B., Chen, D., Cui, S., Song, H., Wang, R., Chu, X., Zhu, X. and Chen, L. (2019) TFAP2C-Activated MALAT1 Modulates the Chemo-resistance of Docetaxel-Resistant Lung Adenocarcinoma Cells. Molecular Therapy Nucleic Acids, 14, 567-582. https://doi.org/10.1016/j.omtn.2019.01.005
|
[15]
|
Zhou, Q., Liu, L., Zhou, J., Chen, Y., Xie, D., Yao, Y. and Cui, D. (2021) Novel Insights into MALAT1 Function as a MicroRNA Sponge in NSCLC. Frontiers in Oncology, 11, Article 758653. https://doi.org/10.3389/fonc.2021.758653
|
[16]
|
Chen, W., Zhao, W., Chen, S., Zhang, L., Guo, Z., Wang, L., Wang, J., Wan, Z., Hong, Y. and Yu, L. (2018) Expression and Correlation of MALAT1 and SOX9 in Non-Small Cell Lung Cancer. The Clinical Respiratory Journal, 12, 2284-2291.
https://doi.org/10.1111/crj.12906
|
[17]
|
Esfandi, F., Taheri, M., Omrani, M.D., Shadmehr, M.B., Arsang-Jang, S., Shams, R. and Ghafouri-Fard, S. (2019) Expression of Long Non-Coding RNAs (lncRNAs) Has Been Dysregulated in Non-Small Cell Lung Cancer Tissues. BMC Cancer, 19, Article No. 222. https://doi.org/10.1186/s12885-019-5435-5
|
[18]
|
Pan, Y., Liu, L., Cheng, Y., Yu, J. and Feng, Y. (2020) Amplified LncRNA PVT1 Promotes Lung Cancer Proliferation and Metastasis by Facilitating VEGFC Expression. Biochemistry and Cell Biology, 98, 676-682.
https://doi.org/10.1139/bcb-2019-0435
|
[19]
|
Xiao, M., Feng, Y., Liu, C. and Zhang, Z. (2018) Prognostic Values of Long Noncoding RNA PVT1 in Various Carcinomas: An Updated Systematic Review and Meta-Analysis. Cell Prolifer-ation, 51, e12519.
https://doi.org/10.1111/cpr.12519
|
[20]
|
李靖凯, 王伟, 周冬冬. LncRNA PVT1在非小细胞肺癌中的表达及与铂类化疗敏感性的关系[J]. 热带医学杂志, 2021, 21(4): 472-476.
|
[21]
|
Xin, Y., Li, Z., Zheng, H., Chan, M.T.V., Ka Kei Wu, W. (2017) CCAT2: A Novel Oncogenic Long Non-Coding RNA in Human Cancers. Cell Proliferation, 50, e12342. https://doi.org/10.1111/cpr.12342
|
[22]
|
Yu, W.L., Yao, J.J., Xie, Z.Z., Huang, Y.J. and Xiao, S. (2021) LncRNA PRNCR1 rs1456315 and CCAT2 rs6983267 Polymorphisms on 8q24 Associated with Lung Cancer. Interna-tional Journal of General Medicine, 14, 255-266.
https://doi.org/10.2147/IJGM.S290997
|
[23]
|
He, L., Du, Z.D., Wang, Y., Meng, R.Q. and Zhao, W.W. (2020) Ef-fects of shRNA on Cisplatin-Resistant Non-Small Cell Lung Cancer Cell A549 via Silencing CCAT2. Journal of Si-chuan University Medical Science Edition, 51, 312-319.
|
[24]
|
芮文秀, 王亮歌. lncRNA CCAT2调控SIRT1蛋白表达激活Wnt/β-catenin通路影响非小细胞肺癌细胞增殖和转[J]. 中国细胞生物学学报, 2021, 43(5): 971-978.
|
[25]
|
Chen, S., Wu, H., Lv, N., Wang, H., Wang, Y., Tang, Q., Shao, H. and Sun, C. (2016) LncRNA CCAT2 Predicts Poor Prognosis and Regulates Growth and Metastasis in Small Cell Lung Cancer. Biomedicine & Pharma-cotherapy, 82, 583-588. https://doi.org/10.1016/j.biopha.2016.05.017
|
[26]
|
Li, X., Lv, F., Li, F., Du, M., Liang, Y., Ju, S., Liu, Z., Wang, B. and Gao, Y. (2020) Long Non Coding RNA H19 Facilitates Small Cell Lung Cancer Tumor-igenesis through miR-140-5p/FGF9 Axis. OncoTargets and Therapy, 13, 3525-3534.
https://doi.org/10.2147/OTT.S245710
|
[27]
|
Zhou, Y. and Xia, Q. (2022) LncRNA H19 Promotes Lung Adenocar-cinoma Progression via Binding to Mutant p53 R175H. Cancers, 14, Article 4486. https://doi.org/10.3390/cancers14184486
|
[28]
|
周建英, 刘震天, 胡珍珍, 等. 肺癌组织中长链非编码RNA-H9的表达与患者免疫功能、炎症反应因子及预后的关系[J]. 中国免疫学杂志, 2021, 37(16): 2012-2016.
|
[29]
|
Ni, W., Yao, S., Zhou, Y., Liu, Y., Huang, P., Zhou, A., Liu, J., Che, L. and Li, J. (2019) Long Noncoding RNA GAS5 Inhibits Progression of Colorectal Cancer by Interacting with and Triggering YAP Phosphorylation and Degradation and Is Neg-atively Regulated by the m6A Reader YTHDF3. Molecular Cancer, 18, Article No. 143.
https://doi.org/10.1186/s12943-019-1079-y
|
[30]
|
Al Mourgi, M., El Askary, A., Gharib, A.F., Alzahrani, R., Ban-jer, H.J., Elsawy, W.H., Al, A.E. and Raafat, N. (2021) Circulating Long Non-Coding RNA GAS5: A Non-Invasive Molecular Marker for Prognosis, Response to Treatment and Survival in Non-Small Cell Lung Cancer. Cancer Investi-gation, 39, 505-513.
https://doi.org/10.1080/07357907.2021.1928167
|
[31]
|
Ma, J., Miao, H., Zhang, H., Ren, J., Qu, S., Da, J., Xu, F. and Zhao, H. (2021) LncRNA GAS5 Modulates the Progression of Non-Small Cell Lung Cancer through Repressing miR-221-3p and Up-Regulating IRF2. Diagnostic Pathology, 16, Article No. 46. https://doi.org/10.1186/s13000-021-01108-0
|
[32]
|
Zhu, L., Zhou, D., Guo, T., Chen, W., Ding, Y., Li, W., Huang, Y., Huang, J. and Pan, X. (2021) LncRNA GAS5 Inhibits Invasion and Migration of Lung Cancer through Influencing EMT Process. Journal of Cancer, 12, 3291-3298.
https://doi.org/10.7150/jca.56218
|
[33]
|
Yang, X., Meng, L., Zhong, Y., Hu, F., Wang, L. and Wang, M. (2021) The Long Intergenic Noncoding RNA GAS5 Reduces Cisplatin-Resistance in Non-Small Cell Lung Cancer through the miR-217/LHPP Axis. Aging, 13, 2864-2884.
https://doi.org/10.18632/aging.202352
|
[34]
|
Fu, Y., Liu, L., Zhan, J., Zhan, H. and Qiu, C. (2021) LncRNA GAS5 Expression in Non-Small Cell Lung Cancer Tissues and Its Correlation with Ki67 and EGFR. American Journal of Translational Research, 13, 4900-4907.
|
[35]
|
Wei, L., Ling, M., Yang, S., Xie, Y., Liu, C. and Yi, W. (2021) Long Noncoding RNA NBAT1 Suppresses Hepatocellular Carcinoma Progression via Competitively Associating with IGF2BP1 and Decreasing c-Myc Expression. Human Cell, 34, 539-549. https://doi.org/10.1007/s13577-020-00464-1
|
[36]
|
Yan, J., Huang, W., Huang, X., Xiang, W., Ye, C. and Liu, J. (2018) A Negative Feedback Loop between Long Noncoding RNA NBAT1 and Sox9 Inhibits the Malignant Progres-sion of Gastric Cancer Cells. Bioscience Reports, 38, BSR20180882. https://doi.org/10.1042/BSR20180882
|
[37]
|
Zheng, T., Li, D., He, Z., Feng, S. and Zhao, S. (2018) Long Noncod-ing RNA NBAT1 Inhibits Autophagy via Suppression of ATG7 in Non-Small Cell Lung Cancer. American Journal of Cancer Research, 8, 1801-1811.
|
[38]
|
Lv, D., Bi, Q., Li, Y., Deng, J., Wu, N., Hao, S. and Zhao, M. (2021) Long Non-Coding RNA MEG3 Inhibits Cell Migration and Invasion of Non-Small Cell Lung Cancer Cells by Regulating the miR-21-5p/PTEN Axis. Molecular Medicine Reports, 23, Article No. 191. https://doi.org/10.3892/mmr.2021.11830
|
[39]
|
Wang, D.L., Yuan, P. and Tian, J.Y. (2020) Expression of Long Noncoding RNA NBAT1 Is Associated with the Outcome of Patients with Non-Small Cell Lung Cancer. Revista da As-sociação Médica Brasileira, 66, 898-903.
https://doi.org/10.1590/1806-9282.66.7.898
|
[40]
|
Xue, S., Lu, F., Sun, C., Zhao, J., Zhen, H. and Li, X. (2021) LncRNA ZEB1-AS1 Regulates Hepatocellular Carcinoma Progression by Targeting miR-23c. World Journal of Surgical Oncology, 19, Article No. 121.
https://doi.org/10.1186/s12957-021-02176-8
|
[41]
|
Ruan, L., Chen, W., Zhao, X., Fang, N. and Li, T. (2022) Pre-dictive Potentials of ZEB1-AS1 in Colorectal Cancer Prognosis and Their Correlation with Immunotherapy. Journal of Oncology, 2022, Article ID: 1084555.
https://doi.org/10.1155/2022/1084555
|
[42]
|
Wang, J., Han, X., Yuan, Y., Gu, H., Liao, X. and Jiang, M. (2022) The Value of Dysregulated LncRNAs on Clinicopathology and Survival in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. Frontiers in Genetics, 13, Article 821675. https://doi.org/10.3389/fgene.2022.821675
|
[43]
|
Jin, J., Wang, H., Si, J., Ni, R., Liu, Y. and Wang, J. (2019) ZEB1-AS1 Is Associated with Poor Prognosis in Non-Small-Cell Lung Cancer and Influences Cell Migration and Apoptosis by Repressing ID1. Clinical Science, 133, 381-392.
https://doi.org/10.1042/CS20180983
|
[44]
|
Xie, J., Wu, Y., Bian, X., Chen, D., Gui, Q. and Huang, J. (2018) In-creased Expression of lncRNA ZEB1-AS1 in Non-Small Cell Lung Cancer Is Associated with Poor Prognosis. Interna-tional Journal of Clinical and Experimental Pathology, 11, 3703-3707.
|
[45]
|
Xin, X., Li, Q., Fang, J. and Zhao, T. (2021) LncRNA HOTAIR: A Potential Prognostic Factor and Therapeutic Target in Human Cancers. Frontiers in On-cology, 11, Article 679244. https://doi.org/10.3389/fonc.2021.679244
|
[46]
|
Li, S., Xiong, Q., Chen, M., Wang, B., Yang, X., Yang, M., Wang, Q., Cui, Z. and Ge, F. (2021) Long Noncoding RNA HOTAIR Interacts with Y-Box Pro-tein-1 (YBX1) to Regulate Cell Proliferation. Life Science Alliance, 4, e202101139.
https://doi.org/10.26508/lsa.202101139
|
[47]
|
Zhang, C., Xu, L., Deng, G., Ding, Y., Bi, K., Jin, H., Shu, J., Yang, J., Deng, H., Wang, Z. and Wang, Y. (2020) Exosomal HOTAIR Promotes Proliferation, Migration and Invasion of Lung Cancer by Sponging miR-203. Science China Life Sciences, 63, 1265-1268. https://doi.org/10.1007/s11427-019-1579-x
|
[48]
|
Chen, L., Huang, S., Huang, J., Chen, Q. and Zhuang, Q. (2021) Role and Mechanism of Exosome-Derived Long Noncoding RNA HOTAIR in Lung Cancer. ACS Omega, 6, 17217-17227. https://doi.org/10.1021/acsomega.1c00905
|